ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection
Cancer Research and Treatment. 2015;47(4):853-861 
Glyoxylate Reductase/Hydroxypyruvate Reductase: A Novel Prognostic Marker for Hepatocellular Carcinoma Patients after Curative Resection
Pathobiology. 2013;80(3):155-162
Prognostic analysis of hepatocellular carcinoma greater than 5 cm in diameter after curative resection
HPB. 2019;21:S367
Corrigendum to “Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma”
Disease Markers. 2017;2017:1-1
Peer review report 1 on “Prognostic nomogram for patients with non-B non-C hepatocellular carcinoma after curative liver resection”
International Journal of Surgery. 2017;37:385
Peer review report 2 on “Prognostic nomogram for patients with non-B non-C hepatocellular carcinoma after curative liver resection”
International Journal of Surgery. 2017;37:404
Peer review report 3 on “Prognostic nomogram for patients with non-B non-C hepatocellular carcinoma after curative liver resection”
International Journal of Surgery. 2017;37:395
Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection
Translational Oncology. 2014;7(2):248-255
Effectiveness of the Albumin-bilirubin Score as a Prognostic Factor for Early Recurrence after Curative Hepatic Resection for Hepatocellular Carcinoma
HPB. 2021;23:S163
Low expression of plakoglobin in intratumoral liver tissue is associated with poor survival after curative resection of Hepatocellular Carcinoma
. 2020;